Search results
Showing 1276 to 1290 of 1877 results for do not dos
from expert testimony that in London people who own cars are less likely to do half an hour of active travel in a day than those who...
Evidence-based recommendations on SecurAcath for securing percutaneous catheters.
Devices for remote monitoring of Parkinson's disease (HTG657)
Evidence-based recommendations on Kinesia 360 and KinesiaU (Great Lakes NeuroTechnologies), PDMonitor (PD Neurotechnology), Personal KinetiGraph (Global Kinetics) and STAT-ON (Sense4care) for remote monitoring of Parkinson’s disease.
Evidence-based recommendations on leniolisib (Joenja) for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over.
research. Any explanatory notes(if applicable) Clinicians wishing to do transurethral laser ablation for recurrent non-muscle-invasive...
hearing aids delay the onset or reduce the incidence of dementia. Hearing aids do, however, have the potential to improve functioning...
Evidence-based recommendations on lead-I electrocardiogram (ECG) devices (imPulse, Kardia Mobile, MyDiagnostick and Zenicor-ECG) for detecting symptomatic atrial fibrillation using single time point testing in primary care.
clinical event, outcomes have improved. It is unclear which people are likely to do well with conventional treatment (such as R-CHOP)...
NICE has developed a medtech innovation briefing (MIB) on Aptiva for painful diabetic neuropathy .
Next-generation sequencing panel for solid tumour cancers in children (MIB133)
NICE has developed a medtech innovation briefing (MIB) on the next-generation sequencing panel for solid tumour cancers in children .
NICE has developed a medtech innovation briefing (MIB) on Natural Cycles for monitoring fertility .
Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis (HTG375)
Evidence-based recommendations on ultrasound enhanced catheter-directed thrombolysis for deep vein thrombosis. This involves using ultrasound waves and a drug to break up the clot.
Evidence-based recommendations on lenalidomide (Revlimid) for maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple myeloma in adults.
Evidence-based recommendations on ibrutinib (Imbruvica) for treating chronic lymphocytic leukaemia in adults.
What is the efficacy and safety of remdesivir for people who have been vaccinated against COVID-19?
(Population, Intervention, Comparator, Outcomes) P: people with COVID-19 who do not need supplemental oxygen and are within 7 days of...